The diagnosis and treatment of late-life depression

被引：0

作者：

Rothschild, AJ ^{[1
]}

机构：

[1] HARVARD UNIV,SCH MED,DEPT PSYCHIAT,BOSTON,MA 02115

来源：

JOURNAL OF CLINICAL PSYCHIATRY | 1996年 / 57卷

关键词：

SEROTONIN REUPTAKE INHIBITORS; DRUG-DRUG INTERACTIONS; GERIATRIC DEPRESSION; CLINICAL-PHARMACOLOGY; MAJOR DEPRESSION; ANTI-DEPRESSANT; FLUOXETINE; ANTIDEPRESSANT; SERTRALINE; PAROXETINE;

D O I：

暂无

中图分类号：

B849 [应用心理学];

学科分类号：

040203 ;

摘要：

Depression in the elderly occurs commonly and is a major public health problem. Unfortunately, despite the availability of safe and effective treatments, late-life depression is often underdiagnosed because the symptoms are unrecognized by the patient and the health care provider. Late-life depression is described in this review, with a focus on symptoms, prevalence, diagnosis, and available treatment modalities.

引用

页码：5 / 11

页数：7

共 80 条

[31] FLUOXETINE IMPAIRS CLEARANCE OF ALPRAZOLAM BUT NOT OF CLONAZEPAM [J].